Press Releases and Statements

(PHILADELPHIA) – The Consumer Healthcare Product’s Association’s (CHPA) Health In Hand Educational Foundation held its 9th Annual Gala last night at The Bellevue Hotel in Philadelphia. The widely attended fundraiser brought together 350 attendees from 98 companies across the self-care industry to celebrate and support the Foundation’s critical consumer-focused work to help people live happier, healthier lives through responsible self-care. In addition to highlighting Health In Hand’s key 2024 educational initiatives, the event program also included the announcement of the Foundation’s new board member, Mark Pearson, Reckitt’s Vice President of Marketing Health, and the winners of the 2024 U.S. Self-Care Marketing Awards.

“The president-elect has announced his intention to nominate Robert F. Kennedy, Jr. to serve as Secretary of Health and Human Services. 

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association’s (CHPA) President and CEO Scott Melville released the following statement today in response to FDA’s Proposed Order regarding the status of over-the-counter (OTC) phenylephrine (PE):

CHPA released the below statement following the passage of A1848 by the New Jersey Assembly today. This legislation seeks to ban the sale of over-the-counter (OTC) weight loss diet pills and dietary supplements marketed for weight loss and muscle building to individuals under 18 years old. While CHPA accepts age restrictions on products explicitly marketed for weight loss, recent amendments to the bill have broadened its scope. The changes now unnecessarily encompass general health supplements containing certain ingredients – including creatine and green tea extract – which are commonly used in many products unrelated to weight loss.

CHPA was pleased to announce today that Dr. Doug Bierer has been honored with its prestigious William Cooley Regulatory & Scientific Affairs Career Achievement Award in recognition of his exceptional service and contributions to the consumer healthcare products industry.

(WASHINGTON, DC) – The Health In Hand Foundation today released the following statement announcing the 2024 U.S. Self-Care Marketing Awards finalists. Winners for each category will be announced at the 9th annual Health In Hand Foundation Gala on November 13 at The Bellevue Hotel in Philadelphia. Specific awards will recognize the strategic innovation and marketing expertise of CHPA member companies across over-the-counter (OTC) medicine, consumer medical device, and dietary supplement categories.

The Consumer Healthcare Products Association (CHPA) released the following statement in response to a recent study published in Environment International regarding the presence of metals in certain tampon products. The study did not assess the risk of metal exposure to tampon users.

The Consumer Healthcare Products Association (CHPA) released the following statement today in response to Aylstock, Witkin, Kreis & Overholtz, PLLC filing a Citizen Petition with the U.S. Food and Drug Administration (FDA), requesting the Agency “recall and suspend sales of benzoyl peroxide (BPO) from the US Market due to the presence of benzene.”

CHPA Senior Vice President of Dietary Supplements Duffy MacKay released the following statement today in response to a recent JAMA Network Open Study investigating the prevalence and characteristics of U.S. adults consuming botanicals potentially linked to liver toxicity:

(WASHINGTON, D.C.) – The Consumer Healthcare Products Association (CHPA) today released the following statement after providing input to U.S. House Energy & Commerce Committee Members, U.S. Representatives Larry Bucshon (IN-08) and Diana DeGette (CO-01), following their request for information from industry stakeholders on how Congress can build upon the 21st Century Cures Act and Cures 2.0 to develop and deliver a new generation of treatments:

Consumer Healthcare Products Association (CHPA) President & CEO Scott Melville released the following statement today in response to U.S. Senator Dick Durbin introducing the Dietary Supplement Listing Act: